Undervalued Stocks Based On Cash Flows

Résultats

30

7 nouveau

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

30 entreprises

EntrepriseDernier prix7D RetourRetour 1 anCapitalisation boursièreCible des analystesÉvaluationCroissanceRendement des dividendesL'industrie
1021
HK$18.15-9.9%n/aHK$9.9bHK$26.5422.187.8%n/aCapital Goods
6990
Nouveau
HK$436.209.6%33.3%HK$101.7bHK$547.6442.844.8%n/aPharmaceuticals & Biotech
2338
HK$34.10-13.0%113.9%HK$277.5bHK$45.5222.622.0%2.5%Capital Goods
1364
Nouveau
HK$21.143.7%-17.3%HK$50.3bHK$33.7514.014.5%2.4%Consumer Services
2190
HK$18.14-0.4%-12.8%HK$6.1bHK$30.3121.525.4%1.4%Healthcare
9660
Nouveau
HK$4.083.0%-37.1%HK$59.5bHK$10.9913.776.7%n/aSoftware
2698
HK$25.00-6.4%n/aHK$15.5bHK$40.5116.314.9%2.8%Household
6656
HK$359.80-0.9%n/aHK$88.8bHK$650.2026.333.1%n/aCapital Goods
2315
Nouveau
HK$46.7412.6%107.7%HK$47.6bHK$62.0262.340.4%n/aPharmaceuticals & Biotech
1801
HK$79.604.1%1.5%HK$138.4bHK$117.58147.331.1%n/aPharmaceuticals & Biotech
1180
Nouveau
HK$0.7710.0%5.5%HK$810.2mHK$1.3074.279.9%13.0%Consumer Services
1768
HK$311.60-2.8%n/aHK$67.9bHK$508.5825.223.9%n/aConsumer Retailing
9926
HK$88.053.0%-4.2%HK$81.1bHK$169.3023.046.6%n/aPharmaceuticals & Biotech
1357
HK$3.75-6.9%-58.5%HK$17.1bHK$9.3220.231.4%2.7%Media
9658
HK$9.17-4.3%-40.5%HK$6.0bHK$14.4526.630.5%n/aConsumer Services
1060
HK$0.46-10.8%-52.6%HK$13.6bHK$0.9416.720.4%n/aMedia
2589
HK$107.50-22.8%-18.9%HK$11.3bHK$88.3519.514.3%2.1%Consumer Services
2252
HK$22.94-1.6%42.0%HK$23.7bHK$37.3537.290.1%n/aHealthcare
2145
HK$27.26-4.6%-66.8%HK$10.9bHK$86.008.516.7%5.3%Household
2487
HK$2.83-8.4%-71.8%HK$1.0bHK$11.282.699.3%n/aPharmaceuticals & Biotech
3396
Nouveau
HK$14.09-7.2%58.3%HK$33.2bHK$13.5727.144.5%0.8%Tech
23
HK$12.53-4.1%3.6%HK$33.1bHK$14.260.325.9%4.9%Banks
2235
HK$7.10-2.5%19.9%HK$3.0bHK$11.8163.744.9%n/aHealthcare
2420
HK$4.034.9%24.4%HK$2.0bHK$6.786.522.7%5.7%Retail
Page 1 of 1